Study of bb21217 in Multiple Myeloma

Clinical trial NCT03274219 · COMPLETED

Trial details

NCT number: NCT03274219
Sponsor: 2seventy bio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2017-08-16
Primary completion: 2022-12-02
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.